Stay updated on Atrasentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-09T11:08:13.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-05-01T06:25:28.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly details about the ALIGN Study, including its objectives, inclusion and exclusion criteria, and study design. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    21%
    Check dated 2025-04-16T20:45:38.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:56:32.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:21:44.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T17:48:10.000Z thumbnail image

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.